Treasurer 
Dr. WAHAJUL HAQ
Mailing address
Scientist
Medicinal and Process Chemistry Division
Central Drug Research Institute.
Lucknow 226001
email: w_haq@cdri.res.in
haqw59@rediffmail.com
Educational Qualifications
M. Sc. Ph. D. (Chemistry)
Research and Professional Experience
| 1988-2001 |
Scientist, Division of Biopolymers, Central Drug Research Institute, Lucknow |
| 1991-1992 |
Visiting Scientist, Dept. of Chemistry, University of Arizona, USA |
| 1994.1995 |
Visiting Scientist, Dept. of Chemistry, University of Arizona, USA |
| 08/1995 |
Visiting scientist, Ferring Peptide Production AB, Malmo, Sweden |
| 2003-2004 |
Visiting Scientist, Beckman Research Institute, Duarte, CA, USA |
| 2001-Present |
Scientist, Medicinal Chemistry Division, Central Drug Research Institute, Lucknow |
Fields of specialization
Peptide Chemistry, Bioorganic & Medicinal Chemistry.
Areas of interest
Synthesis purification and analysis of peptides and Development of new methodologies.
Number of Publications
more than 90 in peer reviewed journals.
Patents
Indian (15), US Patent (3) PCT Patent (5)
Professional Experience
Development of methodologies for the synthesis of peptides and oligonucleotides, development of synthetic peptide based diagnostic kit for the diagnosis of Aspergillosis and development of methodologies for the development of peptide based vaccines. Development of new methods/reagents have been developed for the synthesis of difficult sequences both for solid phase and solution phase of peptide synthesis. Chiral synthesis of unusual amino acids and chemoenzymatic synthesis and methods standardized for optical resolution of amino acids by chemienzymatic methodsConformational studies on bio-active peptides have been carried out by 2D NMR and computer modeling studies to correlate the conformational features of the peptide with their biological activity as well as their interaction with membrane/lipids. Synthesis of small heterocyclic compounds and their combinatorial libraries as antifungal/anti-infective agents as well as anti-diabetic agents.
| 
